Bloch-Queyrat C - Search Results

1

Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.

Allenbach Y, Benveniste O, Decostre V, Canal A, Eymard B, Herson S, Bloch-Queyrat C, Hogrel JY. Allenbach Y, et al. Neuromuscul Disord. 2012 Nov;22(11):980-6. doi: 10.1016/j.nmd.2012.05.004. Epub 2012 Jun 26. Neuromuscul Disord. 2012. PMID: 22738680

2

Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).

Arlet JB, Dimitri D, Pagnoux C, Boyer O, Maisonobe T, Authier FJ, Bloch-Queyrat C, Goulvestre C, Heshmati F, Atassi M, Guillevin L, Herson S, Benveniste O, Mouthon L. Arlet JB, et al. Neuromuscul Disord. 2006 May;16(5):334-6. doi: 10.1016/j.nmd.2006.03.002. Epub 2006 Apr 17. Neuromuscul Disord. 2006. PMID: 16616848

3

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O. Benveniste O, et al. Arthritis Rheum. 2011 Jul;63(7):1961-71. doi: 10.1002/art.30344. Arthritis Rheum. 2011. PMID: 21400483 Free article.

4

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

Hermine O, Mariette X, Tharaux PL, Resche-Rigon M, Porcher R, Ravaud P; CORIMUNO-19 Collaborative Group. Hermine O, et al. JAMA Intern Med. 2021 Jan 1;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820. JAMA Intern Med. 2021. PMID: 33080017 Free PMC article. Clinical Trial.

5

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.

Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.

6

Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort.

Berthelot L, Jamin A, Viglietti D, Chemouny JM, Ayari H, Pierre M, Housset P, Sauvaget V, Hurtado-Nedelec M, Vrtovsnik F, Daugas E; HSPrognosis Group; Monteiro RC, Pillebout E; members of the HSPrognosis Group. Berthelot L, et al. Nephrol Dial Transplant. 2018 Sep 1;33(9):1579-1590. doi: 10.1093/ndt/gfx300. Nephrol Dial Transplant. 2018. PMID: 29126311

7

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.

CORIMUNO-19 Collaborative group. CORIMUNO-19 Collaborative group. Lancet Respir Med. 2021 Mar;9(3):295-304. doi: 10.1016/S2213-2600(20)30556-7. Epub 2021 Jan 22. Lancet Respir Med. 2021. PMID: 33493450 Free PMC article. Clinical Trial.

8

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.

CORIMUNO-19 Collaborative group. CORIMUNO-19 Collaborative group. Lancet Rheumatol. 2022 Jan;4(1):e24-e32. doi: 10.1016/S2665-9913(21)00315-5. Epub 2021 Nov 17. Lancet Rheumatol. 2022. PMID: 34812424 Free PMC article.

9

Complete remission in refractory relapsing polychondritis with intravenous immunoglobulins.

Terrier B, Aouba A, Bienvenu B, Bloch-Queyrat C, Delair E, Mallet J, Mahr A, Guillevin L. Terrier B, et al. Clin Exp Rheumatol. 2008 Jan-Feb;26(1):136-8. Clin Exp Rheumatol. 2008. PMID: 18328162 No abstract available.

10

Tumor-Like Presentation of Primary Angiitis of the Central Nervous System.

de Boysson H, Boulouis G, Dequatre N, Godard S, Néel A, Arquizan C, Detante O, Bloch-Queyrat C, Zuber M, Touzé E, Bienvenu B, Aouba A, Guillevin L, Naggara O, Pagnoux C; French Vasculitis Study Group. de Boysson H, et al. Stroke. 2016 Sep;47(9):2401-4. doi: 10.1161/STROKEAHA.116.013917. Epub 2016 Jul 28. Stroke. 2016. PMID: 27470990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters